Insider Trading: Aegerion Pharmaceuticals Inc (AEGR.O)
AEGR.O on Nasdaq
60.02USD
21 May 2013
60.02USD
21 May 2013
Price Change (% chg)
$-0.09 (-0.15%)
$-0.09 (-0.15%)
Prev Close
$61.57
$61.57
Open
$60.20
$60.20
Day's High
$61.19
$61.19
Day's Low
$59.50
$59.50
Volume
350,685
350,685
Avg. Vol
625,928
625,928
52-wk High
$63.72
$63.72
52-wk Low
$12.86
$12.86
| FITZPATRICK MARK J | Options Exercised: 0 | ||
| Trade Date: | Thursday, 22 Mar 2012 | Price: | 14.15 |
| Title: | Chief Financial Officer | Shares Held: | 500 |
| Type Traded: | Direct | Net Change in Shares This Filing: | 500 |
Institutional Holders
| % Shares Owned: | 0.00% |
| # of Holders: | 150 |
| Total Shares Held: | 30,774,051 |
| 3 Mo. Net Change: | 5,843,069 |
| # New Positions: | 44 |
| # Closed Positions: | 13 |
| # Increased Positions: | 110 |
| # Reduced Positions: | 46 |
| # Net Buyers: | 64 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
David Scheer |
60 | 2005 | Independent Chairman of the Board |
Marc Beer |
48 | 2010 | Chief Executive Officer, Director |
Mark Fitzpatrick |
49 | 2011 | Chief Financial Officer |
Anne Cook |
50 | 2011 | Senior Vice President, General Counsel, Secretary |
Martha Carter |
59 | 2011 | Chief Regulatory Officer and Senior Vice President |
Mark Sumeray |
46 | 2011 | Chief Medical Officer |
Anne VanLent |
2013 | Director | |
Sol Barer |
2011 | Independent Director | |
Antonio Gotto |
76 | 2006 | Independent Director |
Sandford Smith |
65 | 2012 | Independent Director |
Paul Thomas |
56 | 2011 | Independent Director |
Amanda Murphy |
IR Contact Officer |

